Molecular biological analysis for apoptosis induction and variation of cytoskeltons & adhesion molecules in malignant melanoma
Molecular biological analysis for apoptosis induction and variation of cytoskeltons & adhesion molecules in malignant melanoma
批准号:
12670815
负责人:
TAKAGI Hajime
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Basic research1. Immunohistochemically we confirmed sequential bioimmunochemotherapy induced apoptosis for mouse melanoma cells. 2. We checked drug sensitivity of cultured human melanoma cells by FACScan. 3. Variation of cytoskelton, especially vimentin, were examined with immunofluorescent technique. But analysis was not enough, because of technical trouble. 4. Animal experiments were not done. We did not prepare to a favorable environment. 5. We compared extent of multidrug-resistance-associated protein between before and after chemotherapy. 6. We have been trying establish cell line of drug resistant melanoma cells.Clinical research1. We refer to the apoptosis cells, apoptosis- related gene/protein, and adhesion molecules by melanoma patients specimens immunohistochemically. 2. We measured melanoma inhibitory activity by ELISA method, and checked with association of the value and clinical course. 3. We evaluated of combination chemotherapy (DAC-Tam) for advanced malignant melanoma.SummaryWe cannot show enough results in this periods, but we got some promising products. We will keep this projects going on some experiments.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kubo H, Matsumoto K, Funahashi M, Takagi H, Kitajima Y, Taniguchi S and Saida T: "Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in cyngeneic mice"Melanoma Research. 10. 223-229 (2000
Kubo H、Matsumoto K、Funahashi M、Takagi H、Kitajima Y、Taniguchi S 和 Saida T:“使用顺铂、干扰素-β 和白细胞介素 2 的序贯化学免疫疗法抑制新生小鼠中 B16-F1 黑色素瘤的生长”黑色素瘤研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kamiya H, Kanoh H, Ichihashi N, Ichiki Y, Takagi H, and Kitajima Y: "Evaluations of combination chemotherapy (DAC-Tam) for advanced malignant melanoma"Nishinihon J Dermatol. 63. 561-568 (2002)
Kamiya H、Kanoh H、Ichihashi N、Ichiki Y、Takagi H 和 Kitajima Y:“晚期恶性黑色素瘤联合化疗 (DAC-Tam) 的评估”Nishinihon J Dermatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
神谷秀喜他: "進行期悪性黒色腫に対するDAC-Tam 療法の使用経験"西日皮膚. 63. 561-568 (2001)
Hideki Kamiya 等人:“DAC-Tam 治疗晚期恶性黑色素瘤的经验”Nishinichi Skin 63. 561-568 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Kubo et al.: "Sequential chemoimmuno therapy with cisplatin, interferon-β and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice"Melanoma Research. 10. 223-229 (2000)
H. Kubo 等人:“使用顺铂、干扰素-β 和白介素-2 的序贯化学免疫疗法抑制同系小鼠中 B16-F1 黑色素瘤的生长”Melanoma Research 10. 223-229 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Molecular Biological Analysis for the Role of Plasminogen Activator in Wound Healings
-
批准号:08670959
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1996
-
负责人:TAKAGI Hajime
-
依托单位: